Regulators worldwide take action on ranitidine

27 September 2019 - Deborah Wilkes

Regulatory agencies around the world are taking action on medicines containing ranitidine after tests showed some contain "low levels" of a probable human carcinogen called N-nitrosodimethylamine (NDMA).